Article info
PDFLetter
Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis
- Correspondence to Dr Janine A Lamb, Division of Population Health, Health Services Research and Primary Care, The University of Manchester, Manchester M13 9PL, UK; janine.lamb{at}manchester.ac.uk
Citation
Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis
Publication history
- Received April 7, 2020
- Revised May 4, 2020
- Accepted May 5, 2020
- First published May 22, 2020.
Online issue publication
September 14, 2020
Article Versions
- Previous version (22 May 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.